Multiple Myeloma Specialists in MassachusettsPage 5

Shail Maingi, MD

DFCI Network Health Equity and Inclusion Liaison

Hematology

Lauren Guggina, M.D.

Instructor in Dermatology, Harvard Medical School

Hematology

Rachel Rosovsky, MD

Director, Thrombosis Research

Hematology

Rupa Narayan, MD

Hematology

Jacqueline Garcia, MD

Assistant Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School

Hematology

Adam Sperling, M.D.,PH.D.

Director of Basic and Correlative Science, Multiple Myeloma and Cell Therapies; Assistant Professor of Medicine, Harvard Medical School

Oncology

Maureen Achebe, MD, MPH

Director, Non-Malignant Hematology Clinic; Director, Brigham and Women's Hospital Outpatient Infusion Center

Hematology

Marian Harris, M.D., Ph.D.

Director, Laboratory for Molecular Pediatric Pathology

Hematology

Lisa Teot, M.D.

Director of Cytology

Hematology

Virginia Volpe, M.D.

Instructor of Medicine at Harvard Medical School. She is board certified in Internal Medicine, Hematology, and Medical Oncology. She completed her r

Oncology

Irina Gurevich, M.D.

Hematology

Gabriel Griffin, M.D.

Instructor of Pathology, Dana-Farber Cancer Institute and Harvard Medical School

Hematology

Jaime Schneider, MD,PHD

Instructor in Medicine, Harvard Medical School

Hematology

Corey Cutler, M.D.

Director, Adult Stem Cell Transplantation Program; Professor of Medicine, Harvard Medical School

Hematology

Shai Shimony, MD

Chief Medical Resident in 2016-2017. He completed fellowship in Hematology and Haemato-Oncology at Rabin Medical Center in 2020. He completed the DFCI Fole; Instructor in Medicine, Harvard Medical School

Hematology

Humberto Rossi, M.D.

Senior Network Physician

Hematology

Seth Wander, MD,PHD

Associate Physician, Division of Hematology and Medical Oncology

Hematology

Kelly Burke, MD

Instructor in Medicine

Hematology

Antonio Giordano, M.D., PH.D

Clinical Director, Center for Cancer Therapeutic Innovation; Breast Cancer Pathways Medical Director, Dana-Farber Cancer Institute

Hematology

Chi-Joan How, MD

Clinical Chief of Hematology, Brigham and Women's Faulkner Hospital; Instructor in Medicine, Harvard Medical School

Oncology